In the Davis and Regnier Labs, Rachelle Soriano is helping to characterize human beta myosin mutation E525K to determine its effects on sarcomere contraction and organization. The characterization of this mutation will aid in informing drug therapeutics, specifically for myosin activator drugs, and determining this mutations role in patients with dilated cardiomyopathy.